[Rett's syndrome in the Spanish population]

Autor: M, Pineda, A, Aracil, A, Vernet, M, Espada, E, Cobo, R, Arteaga, J, Artigas, C, Barrionuevo, L, Bautista-González, R, Berenguer-Molla, J, Caballero, J, Cabrera, J, Campistol, J, Campos, C, Casas-Fernández, M, Castelló, M, Castro-Gago, P, Castroviejo, J, Colomer, P, Delgado, R, Domingo, A, Domínguez-Jiménez, E, Fernández-Alvarez, J, García-Aymerich, R, Vidal

Publikováno v: Revista de neurologia. 28(1)

Rett syndrome was described in 1966 and became known through the English medical literature in 1983. There are typical and atypical forms. The objective of this study was to record the cases diagnosed in Spain and discover their clinical characterist

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8d49fd75c1a70ea4a83d0488d8cf6472
https://pubmed.ncbi.nlm.nih.gov/10101777

A Comparative Multicenter Cohort Study Evaluating the Long-Term Influence of the Strict Lockdown during the First COVID-19 Wave on Lung Cancer Patients (ARTEMISIA Trial).

Autor: Molinier, Olivier¹ (AUTHOR) omolinier@ch-lemans.fr, Guguen, Camille¹ (AUTHOR), Marcq, Marie² (AUTHOR), Chene, Anne-Laure³ (AUTHOR), Masson, Philippe⁴ (AUTHOR), Bigot, Frédéric⁵ (AUTHOR) frederic.bigot@ico.unicancer.fr, Denis, Fabrice⁶ (AUTHOR) f.denis@ilcgroupe.fr, Empereur, Fabienne⁷ (AUTHOR), Saulnier, Philippe⁸ (AUTHOR), Urban, Thierry⁹ (AUTHOR) thurban@chu-angers.fr

Publikováno v: Cancers. Dec2023, Vol. 15 Issue 24, p5729. 16p.

Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.

Autor: Spinner CD; TUM School of Medicine and Health, Department of Clinical Medicine, Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich, 81675, Munich, Germany. christoph.spinner@mri.tum.de., Bell S; Division of Population Health and Genomics, University of Dundee, Ninewells Hospital, Dundee, Scotland., Einsele H; Department of Internal Medicine II, University Hospital Würzburg, 97080, Würzburg, Germany., Tremblay C; Research Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, H2X 0C1, Canada.; Department of Microbiology, Infectiology and Immunology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada., Goldman M; Université Libre de Bruxelles, Brussels, Belgium., Chagla Z; McMaster University, Hamilton, ON, Canada., Finckh A; University of Geneva, Geneva, Switzerland., Edwards CJ; NIHR Southampton Clinical Research Facility, University Hospital Southampton, NHS Foundation Trust, Southampton Hampshire, UK., Aurer I; University Hospital Center Zagreb Kišpatićeva ul. 12, and Medical School, University of Zagreb, Šalata 3, 10000, Zagreb, Croatia., Launay O; Université Paris Cité; Inserm CIC1417, F-CRIN I REIVAC; Assistance, Publique Hôpitaux de Paris, Cochin Hospital, Paris, France., Casañas I Comabella C; Evidera, Evidence, Value and Access by PPD, Granta Park Great Abington, Cambridge, UK., James S; Evidera, Evidence, Value and Access by PPD, Paris, France., Dube S; Epidemiology, Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, UK., Borkowska K; Evidera, Evidence, Value and Access by PPD, Granta Park Great Abington, Cambridge, UK., Jah F; Medical Affairs, BioPharmaceuticals Medical, AstraZeneca, Hamburg, Germany., Kandeil W; Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Baar, Switzerland., Yokota RTC; P95 Epidemiology & Pharmacovigilance, Leuven, Belgium., Artaud C; Medical Affairs, Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Courbevoie, France., Gottenberg JE; Strasbourg University Hospital, Université de Strasbourg, 67000, Strasbourg, France., Gesualdo L; Renal, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy., Bertrand D; Department of Nephrology and Transplantation, University of Rouen, Rouen, France., Arnetorp S; Health Economics & Payer Evidence, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Magiorkinis G; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 115 72, Athens, Greece.

Publikováno v: Advances in therapy [Adv Ther] 2024 Dec 16. Date of Electronic Publication: 2024 Dec 16.